Source:http://linkedlifedata.com/resource/pubmed/id/17499288
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2007-6-18
|
pubmed:abstractText |
Since the implementation of widespread serum total prostate specific antigen based screening, the risk of prostate cancer over diagnosis has become a concern. We evaluated the amount of possible over and under diagnosis of prostate cancer in an asymptomatic screening population with a total prostate specific antigen of 2.0 to 3.9 (lower range) and 4.0 to 10.0 ng/ml (higher range).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0022-5347
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
178
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
93-7; discussion 97
|
pubmed:meshHeading |
pubmed-meshheading:17499288-Adult,
pubmed-meshheading:17499288-Aged,
pubmed-meshheading:17499288-Austria,
pubmed-meshheading:17499288-Humans,
pubmed-meshheading:17499288-Male,
pubmed-meshheading:17499288-Mass Screening,
pubmed-meshheading:17499288-Middle Aged,
pubmed-meshheading:17499288-Prostate-Specific Antigen,
pubmed-meshheading:17499288-Prostatic Neoplasms
|
pubmed:year |
2007
|
pubmed:articleTitle |
Under diagnosis and over diagnosis of prostate cancer in a screening population with serum PSA 2 to 10 ng/ml.
|
pubmed:affiliation |
Department of Urology, Medical University Innsbruck and Institute of Analytical Chemistry and Radiochemistry, Innsbruck, Austria. alexandre.pelzer@uki.at
|
pubmed:publicationType |
Journal Article
|